Impact of the Time Interval Between Primary Debulking Surgery and Start of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer.

Cancer Manag Res · 2021 · PMC8275047 · PMID 34262349

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although our data only showed a trend towards better OS in the intermediate group, most patients now receive multiple post-progression treatments, including surgery, chemotherapy and biological-targeted therapies, which can significantly confound and dilute the effects of the time interval to chemotherapy on the OS endpoint.

also in 53,322 other papers

borderline significantno p-value reported

In our entire cohort, we found a borderline significant of higher optimal debulking rate in the intermediate group.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.